Review
[Progress on targeting TRAIL's receptor as antitumor strategy]
[Article in
Chinese]
Affiliations
- PMID: 21351465
Item in Clipboard
Review
[Progress on targeting TRAIL's receptor as antitumor strategy]
[Article in
Chinese]
Yao Xue Xue Bao.
2009 Dec.
Abstract
There exist two major apoptotic signaling pathways: the intrinsic mitochondria-mediated pathway, and the extrinsic death receptor-induced pathway. TNF-related apoptosis-inducing ligand (TRAIL), which is the ligand for death receptor 4 (DR4) and death receptor 5 (DR5) and induces apoptosis by ligation with DR4 or DR5. We review the characteristic of TRAIL and its receptors, the mechanism of apoptosis induced by TRAIL, the distribution of death receptors in cancer, and applications and prospects of TRAIL signaling pathway in the treatment of cancer.
Similar articles
-
TRAIL receptor signalling and modulation: Are we on the right TRAIL?Cancer Treat Rev. 2009 May;35(3):280-8. doi: 10.1016/j.ctrv.2008.11.006. Epub 2008 Dec 30. Cancer Treat Rev. 2009. PMID: 19117685 Review.
-
Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity.Oncogene. 2016 Mar 10;35(10):1261-70. doi: 10.1038/onc.2015.180. Epub 2015 Jun 8. Oncogene. 2016. PMID: 26050621
-
Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL.Oncol Rep. 2015 Apr;33(4):1947-55. doi: 10.3892/or.2015.3793. Epub 2015 Feb 10. Oncol Rep. 2015. PMID: 25672292
-
Casticin, a flavonoid, potentiates TRAIL-induced apoptosis through modulation of anti-apoptotic proteins and death receptor 5 in colon cancer cells.Oncol Rep. 2013 Feb;29(2):474-80. doi: 10.3892/or.2012.2127. Epub 2012 Nov 7. Oncol Rep. 2013. PMID: 23135489
-
TRAIL as a target in anti-cancer therapy.Cancer Lett. 2009 Nov 18;285(1):1-5. doi: 10.1016/j.canlet.2009.02.029. Epub 2009 Mar 18. Cancer Lett. 2009. PMID: 19299078 Review.